Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder

The Subgenual Anterior Cingulate Cortex in Mood Disorders

(2016) Wayne C. Drevets et al.   CNS SPECTRUMS

Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing

(2012) Jie Liu et al.   BIPOLAR DISORDERS

Investigation of Cortical Thickness Abnormalities in Lithium-Free Adults With Bipolar I Disorder Using Cortical Pattern Matching

(2011) Lara C. Foland-Ross et al.   AMERICAN JOURNAL OF PSYCHIATRY

Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder

(2011) Takuji Uemura et al.   BIPOLAR DISORDERS

Markers of Glutamate Synaptic Transmission and Plasticity Are Increased in the Anterior Cingulate Cortex in Bipolar Disorder

(2010) Sharon L. Eastwood et al.   BIOLOGICAL PSYCHIATRY

Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders

(2010) Cagri Yüksel et al.   BIOLOGICAL PSYCHIATRY

The Bcl-2 Gene Polymorphism rs956572AA Increases Inositol 1,4,5-Trisphosphate Receptor–Mediated Endoplasmic Reticulum Calcium Release in Subjects with Bipolar Disorder

(2010) Rodrigo Machado-Vieira et al.   BIOLOGICAL PSYCHIATRY

Glutamatergic Modulators: The Future of Treating Mood Disorders?

(2010) Carlos Zarate et al.   HARVARD REVIEW OF PSYCHIATRY

Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus

(2009) Michael D. Hammonds et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Bcl-2 Polymorphism Influences Gray Matter Volume in the Ventral Striatum in Healthy Humans

(2009) Giacomo Salvadore et al.   BIOLOGICAL PSYCHIATRY

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

(2009) Lakshmi N Yatham et al.   BIPOLAR DISORDERS

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia

(2009) Jun-Feng Wang et al.   BIPOLAR DISORDERS

Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders

(2009) Rodrigo Machado-Vieira et al.   CURRENT PHARMACEUTICAL DESIGN

Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients

(2009) Hyung-Wook Kim et al.   NEUROBIOLOGY OF DISEASE

Cell death mechanisms in the early stages of acute glutamate neurotoxicity

(2009) Alok Kumar et al.   NEUROSCIENCE RESEARCH

The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders

(2009) Rodrigo Machado-Vieira et al.   NEUROSCIENTIST

Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: A proton magnetic resonance spectroscopy study

(2009) Rhandi Senaratne et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania

(2008) Dost Öngür et al.   BIOLOGICAL PSYCHIATRY

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

(2008) M J Lan et al.   MOLECULAR PSYCHIATRY

Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol

(2008) M Colla et al.   MOLECULAR PSYCHIATRY